XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss) [Member]
Treasury Stock [Member]
Common stock, shares outstanding, beginning balance at Dec. 31, 2019     17,363,000          
Stockholders' equity, beginning balance at Dec. 31, 2019 $ 503,492   $ 1,085 $ 123,281 $ 390,363   $ (11,237) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 69,829       69,829      
Total other comprehensive income (loss), net of tax 3,846           3,846  
Cash dividends declared (35,838)       (35,838)      
Share-based compensation 3,766     3,766        
Exercise of stock options, issuance of other compensation-related equity awards, net of awards surrendered, shares     27,000          
Exercise of stock options, issuance of other compensation-related equity awards, net of awards surrendered $ (470)   $ 0 (1,437)       967
Treasury shares purchased, shares (125,000)              
Treasury stock purchased $ (4,322)             (4,322)
Common stock, shares outstanding, ending balance at Dec. 31, 2020     17,265,000          
Stockholders' equity, ending balance at Dec. 31, 2020 534,195 $ (6,108) $ 1,085 125,610 418,246 $ (6,108) (7,391) (3,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 76,870       76,870      
Total other comprehensive income (loss), net of tax (12,590)           (12,590)  
Cash dividends declared (36,806)       (36,806)      
Share-based compensation 3,316     3,316        
Exercise of stock options, issuance of other compensation-related equity awards, net of awards surrendered, shares     66,000          
Exercise of stock options, issuance of other compensation-related equity awards, net of awards surrendered $ (177)   $ 0 (2,415)       2,238
Common stock, shares outstanding, ending balance at Dec. 31, 2021 17,330,818   17,331,000          
Stockholders' equity, ending balance at Dec. 31, 2021 $ 564,808   $ 1,085 126,511 458,310   (19,981) (1,117)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 71,681       71,681      
Total other comprehensive income (loss), net of tax (137,819)           (137,819)  
Cash dividends declared (37,948)       (37,948)      
Share-based compensation 3,247     3,247        
Exercise of stock options, issuance of other compensation-related equity awards, net of awards surrendered, shares     46,000          
Exercise of stock options, issuance of other compensation-related equity awards, net of awards surrendered $ (821)     (2,702)       1,881
Treasury shares purchased, shares (194,000)              
Treasury stock purchased $ (9,479)             (9,479)
Common stock, shares outstanding, ending balance at Dec. 31, 2022 17,182,753   17,183,000          
Stockholders' equity, ending balance at Dec. 31, 2022 $ 453,669   $ 1,085 $ 127,056 $ 492,043   $ (157,800) $ (8,715)